Analyst firms · Guggenheim · MGNX

Guggenheim MGNX price target and rating history

MacroGenics Inc. (MGNX) · Health Care

Guggenheim rates MacroGenics Inc. (MGNX) Neutral with a $12 price target, as of its latest action on Jul 31, 2024. It has published 5 rating actions on MGNX since November 2021, including 1 upgrade and 3 downgrades.

Current rating
Neutral
Price target
$12
Median target, all firms
Too few
Actions on MGNX
5

Guggenheim price target on MGNX

$30$21$1220222023202420252026
Guggenheim price target on MGNX, each point a stated target, November 2021 to November 2023.

Every Guggenheim rating on MGNX

Questions about Guggenheim and MGNX

What is Guggenheim's price target for MGNX?
Guggenheim's latest stated price target for MacroGenics Inc. (MGNX) is $12, from its action on Nov 7, 2023.
What is Guggenheim's rating on MGNX?
Guggenheim rates MGNX Neutral, a neutral rating, as of Jul 31, 2024.
When did Guggenheim last change its view on MGNX?
On Jul 31, 2024, Guggenheim downgrades to Neutral from Buy.

More MGNX rating histories

All Guggenheim ratingsMGNX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.